The Bullous Pemphigoid 230 (BP230) test is a specialized diagnostic immunoassay designed to detect circulating autoantibodies directed against the BP230 protein, which is an essential structural component of hemidesmosomes in the skin. This blood test is crucial for evaluating vesiculobullous disorders, particularly in diagnosing autoimmune blistering conditions like bullous pemphigoid. By identifying these specific antibodies, clinicians can differentiate BP from other similar blistering skin diseases. Measuring BP230 antibody levels helps confirm clinical diagnoses, evaluates the underlying immune response, and assists healthcare providers in monitoring disease activity and therapeutic effectiveness over time.